Hospital del Mar -ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2009

  1. A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/ emtricitabine in HIV-1-infected patients with virological suppression

    Journal of Acquired Immune Deficiency Syndromes, Vol. 51, Núm. 3, pp. 290-297

  2. Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a lpv/r-containing haart: The atazip study

    Journal of Acquired Immune Deficiency Syndromes, Vol. 51, Núm. 1, pp. 29-36